Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1211.4000 10.60 (0.88%)

NSE Aug 08, 2025 15:31 PM

Volume: 2.4M

Dr. Reddy's Laboratories Ltd.

30 Oct 2023

1211.40

0.88%

Dr Reddy's Labs (HOLD): One-offs fuel PAT beat; India business still soft

Hold: Dr. Reddy's Laboratories Ltd.

Target

BOB Capital Markets Ltd.

Q2 revenue in line but PAT outdid consensus by 22% on account of PLI benefits, litigation settlement and interest income

Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.